Antiplatelet Therapy Duration After TAVI

We are studying whether a shorter 3-month antiplatelet therapy is as effective as the standard 12-month therapy after TAVI. The goal is to see if it reduces complications and bleeding risks.

>2 years6-10 visitsEfficacy phase (II)Confirmation phase (III)No PlaceboPartially RemoteStandard MedicinesOralCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Aspirine Protect
Aspirine Protect is a low-dose aspirin taken to help prevent blood clots and lower the risk of heart attack and stroke.
Kardegic
Kardegic is a medicine used to help prevent blood clots and reduce the risk of heart attack and stroke.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Acetylsalicylic Acid
Acetylsalicylic acid is a substance that reduces pain, fever, and inflammation and can help prevent blood clots.
D
l-Lysine Acetylsalicylate
l-Lysine acetylsalicylate is an aspirin-type substance that relieves pain and fever, reduces inflammation, and can help prevent blood clots.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aas
Abrea
Acard

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire D'Angers
Cardiologie
Angers, France
University Hospital Of Clermont-Ferrand
Cardiologie
Beaumont, France
Centre Hospitalier Universitaire De Bordeaux
Cardiologie
Bordeaux, France
Sponsor: Centre Hospitalier Universitaire De Caen Normandie
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.